Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

OptimizeRx (OPRX) Gross Margin (2016 - 2025)

OptimizeRx (OPRX) has disclosed Gross Margin for 13 consecutive years, with 74.75% as the latest value for Q4 2025.

  • Quarterly Gross Margin rose 661.0% to 74.75% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 67.25% through Dec 2025, up 280.0% year-over-year, with the annual reading at 67.25% for FY2025, 280.0% up from the prior year.
  • Gross Margin hit 74.75% in Q4 2025 for OptimizeRx, up from 67.2% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 74.75% in Q4 2025 to a low of 54.54% in Q1 2021.
  • Historically, Gross Margin has averaged 61.94% across 5 years, with a median of 62.1% in 2024.
  • Biggest five-year swings in Gross Margin: skyrocketed 863bps in 2021 and later plummeted -768bps in 2023.
  • Year by year, Gross Margin stood at 61.0% in 2021, then increased by 4bps to 63.37% in 2022, then decreased by -1bps to 62.89% in 2023, then rose by 8bps to 68.15% in 2024, then rose by 10bps to 74.75% in 2025.
  • Business Quant data shows Gross Margin for OPRX at 74.75% in Q4 2025, 67.2% in Q3 2025, and 63.83% in Q2 2025.